Wall Street Zen Upgrades The Pennant Group (NASDAQ:PNTG) to Buy

The Pennant Group (NASDAQ:PNTG) was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Saturday.

Several other research analysts have also weighed in on the stock. Stephens reissued an “overweight” rating and set a $40.00 price objective on shares of The Pennant Group in a research note on Thursday, October 9th. Truist Financial cut their target price on shares of The Pennant Group from $32.00 to $28.00 and set a “hold” rating on the stock in a report on Wednesday, July 16th. Wells Fargo & Company decreased their price target on shares of The Pennant Group from $31.00 to $29.00 and set an “equal weight” rating for the company in a report on Thursday, August 14th. Jefferies Financial Group began coverage on shares of The Pennant Group in a research report on Friday, October 24th. They issued a “buy” rating and a $30.00 price objective for the company. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of The Pennant Group in a research note on Wednesday. Two investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, The Pennant Group currently has an average rating of “Hold” and a consensus target price of $31.75.

The Pennant Group Stock Up 7.5%

NASDAQ:PNTG opened at $25.54 on Friday. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.08. The Pennant Group has a 12-month low of $21.18 and a 12-month high of $34.27. The stock’s fifty day simple moving average is $24.77 and its 200-day simple moving average is $25.82. The firm has a market capitalization of $883.43 million, a P/E ratio of 34.05, a P/E/G ratio of 2.10 and a beta of 1.39.

The Pennant Group (NASDAQ:PNTG) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.30 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.01. The Pennant Group had a return on equity of 9.37% and a net margin of 3.15%.The business had revenue of $229.04 million during the quarter, compared to the consensus estimate of $221.96 million. The Pennant Group has set its FY 2025 guidance at 1.140-1.180 EPS. Equities research analysts expect that The Pennant Group will post 0.75 earnings per share for the current year.

Institutional Trading of The Pennant Group

A number of institutional investors have recently modified their holdings of PNTG. Cubist Systematic Strategies LLC increased its stake in The Pennant Group by 205.9% in the 1st quarter. Cubist Systematic Strategies LLC now owns 97,527 shares of the company’s stock valued at $2,453,000 after buying an additional 65,640 shares during the last quarter. Belpointe Asset Management LLC bought a new position in shares of The Pennant Group in the 2nd quarter valued at about $211,000. Mackenzie Financial Corp grew its holdings in shares of The Pennant Group by 25.2% in the 1st quarter. Mackenzie Financial Corp now owns 22,446 shares of the company’s stock valued at $565,000 after acquiring an additional 4,522 shares in the last quarter. XTX Topco Ltd acquired a new stake in shares of The Pennant Group in the first quarter valued at about $285,000. Finally, Pinnacle Associates Ltd. bought a new stake in The Pennant Group during the second quarter worth about $1,104,000. 85.88% of the stock is currently owned by institutional investors.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.